Comparative study of efficacy 4 lasers: PDL, QSwitch-Nd-YAG, CO2 and CO2+Qswitch-Nd-YAG in treatment of cutaneous macular amyloidosis

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181217042026N1

Enrollment

Registered

2019-01-15

Start date

2018-09-23

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cutaneous macular amyloidosis. Amyloidosis of skin

Interventions

Intervention 1: 1st Intervention group: the first quarter of ulcer treated with PDL laser. Intervention 2: 2th Intervention group: the second quarter of ulcer treated with QSwitch-Nd-YAG laser. Interv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with cutaneous macular amyloidosis referred to Dermatology Clinic of Ahvaz Imam Khomeini Hospital

Exclusion criteria

Exclusion criteria: history of allergy due to laser therapy

Design outcomes

Primary

Measure	Time frame
Ulcer improvement. Timepoint: after laser therapy and 4 months after that. Method of measurement: observation of ulcer area.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForough Ghanatir

Ahvaz University of Medical Sciences

ghanatir.f@ajums.ac.ir+98 61 3587 4366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026